Holdings. View complete YINN exchange traded fund holdings for better informed ETF trading. Lens & Shutter Holdings Ltd. 8 million shares. 97. ETF Channel Staff - Friday, October 20, 6:48 AM. 10(-0. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. 86 Prior Close 70. Comparing the most. 35% ; Sectors:. Looking at the chart above, XBI's low point in its 52 week range is $72. IBB's and XBI's Top Holdings are About to Break Out. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI. 1. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. Performance and Risk So far this year, XBI has added roughly 1. $5. Performance and Risk The ETF has lost about -9. Growth of Hypothetical $10,000. SPDR S&P Biotech ETF Stock Up 1. LABD. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. Top basket holdings are as of the date indicated and may not be representative of the funds current or future investments. ARGX. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Brazil. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 13%) Gold 1,980. 1. 51 on Tuesday. Top 10 Holdings XBI. XBI, whose index recently expanded, also owns only a handful of established biotech companies. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. Only one of these, AbbVie, is a. View complete WCLD exchange traded fund holdings for better informed ETF trading. 84. A few losers won't cause XBI to crash. LABU. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. XBI has traded between $62. Performance and Risk The ETF has lost about -29. XBI’s Holdings. 57 billion. Based on its analysis of these factors, SSGA Funds Management, Inc. More XBI Holdings Current Portfolio Date Nov 20, 2023; Equity Holdings 132; Bond Holdings 0; Other Holdings 3 % Assets in Top 10 Holdings 16. 38% vs. Performance and Risk The ETF has lost about -9. 79 in February 2021 and has fallen over (50%) to $76. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. The Fund's prospectus and statement of additional information dated October 31, 2015, are incorporated by reference into this. The top ten holdings in IBB make up 51% of the fund, while the top ten in XBI only account for 12% of the fund. Rated on Jun 30, 2023 Published on Jun 30. total market composite index. Performance. Expense ratio and liquidity are average for the group. 58%: Halozyme Therapeutics Inc:How To Invest / Fund Directory / ARK Genomic Revolution ETF vs SPDR S&P Biotech ETF . 5% year-to-date and 38. ETF strategy - SPDR® S&P BIOTECH ETF - Current price data, news, charts and performanceSee the company profile for SPDR S&P Biotech ETF (XBI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. Holdings: 266: Inception Date: Feb 5, 2001: About IBB Fund Home Page The iShares Biotechnology ETF (IBB) is an exchange-traded fund that is based on the NYSE Biotechnology index. SPDR® S&P Biotech ETF (XBI) latest earnings report: revenue, EPS, surprise, history, news and analysis. ETFs are subject to market fluctuation and the risks of their underlying investments. XBI focuses on health care investments and follows the S&P Biotech Index. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. Free ratings, analyses, holdings, benchmarks, quotes, and news. February 15, 2023 — 10:47 am EST. 26% rating in the component of Value. 81. Feel free to the browse the list and view the comparisons that are of an interest to you. View complete IBB exchange traded fund holdings for. Neena Mishra May 10, 2023. 93% of its total assets under management. 1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Compare to Open 70. 96%, and is down about -5. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 12% in the last one year (as. 16bn USD. Looking at the chart above, XBI's low point in its 52 week range is $62. XBI Holdings (Seeking Alpha) Risks. With XBI trading at a recent price near $131. Meanwhile, XBI equal weights its holdings. Check out the side-by-side comparison table of IBB vs. Major Holdings. 60 as the 52 week high point — that compares with a last trade of $69. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. Therapeutics Gene Therapy CAR-T Cell Therapy CRSPR Gene Editing. 94 per share, with $107. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. It's trading down (17%) versus LABU, down (68%) in one-year performance. 37% in the last one. 40. The firm has a market cap of $5. S. 00. As I understand it, this attribute was added to the methodology to protect against having too. 61%) 13,857,540 Average : As of close 11/17/2023: Summary; News; Charts;. All 142 XBI Holdings. XBI has an overall POWR Rating of D, equating to a Sell. 75M), Brown Advisory. ARKG vs XBI Fund Comparison . Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. 42 billion worth of net assets. The next columns indicate the amount of XBI stock held by each of the funds holding XBI, followed by the XBI position size held by the fund, and lastly the date of the quarterly filing period the data represents. 35% for XBI, but SBIO yields 2. 79 as the 52 week high point — that compares with a last trade of $116. 96%, and is down about -5. NEW: Experience our best charts yet. 03 per $1,000 of principal). 78% so far this year and in the past one year (as of 11/20/2023), respectively. Meanwhile, XBI equal weights its holdings. 81 and $97. S. 2. Both VHT and XBI are ETFs. Index Dividend Yield The weighted average of the underlyings’ indicated annual dividend A high-level overview of SPDR® S&P Biotech ETF (XBI) stock. XBI has traded between $62. 51 on Tuesday. 81 and $97. 36% of total assets under management. Over a longer time than that, it has no top holdings. Top 10 Holdings 16. SPDR SERIES TRUST's SPDR (R) S&P (R) Biotech ETF (XBI) has disclosed 141 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2023-06-30. Fund size is a good indication of how many other investors trust this fund. 27%: Number of Holdings 29: Price/Book Ratio Price/Book Ratio. 33% so far, and is up roughly 4. The XBI holdings are quite variable probably helped by algos. 01 per share, with $174. 1 Day NAV Change as of Nov 09, 2023. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. 64 billion, a PE ratio of 11. 15%: Country Percentage; United States: 94. 51. 35%. Figure 1 - XBI ETF top 10 holdings (ssga. XBI: Head-To-Head ETF Comparison. 003 on 06/20/23 ; Management Fee 0. Holdings: 136: Inception Date: Jan 31, 2006: About XBI Fund Home Page The SPDR S&P BIOTECH ETF (XBI) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. 🇺🇸. BTEK11. So far this year, XBI has lost about -5. So far this year, XBI has lost about -5. XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar. XBI | A complete SPDR S&P Biotech ETF exchange traded fund overview by MarketWatch. XBI has a lower 5-year return than XLV (-5. Discover historical prices for XBI stock on Yahoo Finance. We daily evaluate future near-term price gain prospects for quality, market-seasoned ETFs, based on the expectations of market. According to 9 analysts, the average rating for IMGN stock is "Strong Buy. 5% position, and no other holding accounts for more than 1. Its price to cash flow multiples is about 13. 01% upside for this ETF looking through to the average analyst targets of the underlying holdings. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 66 +2. 9% vs -5. 80% of total assets under management. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. 1% over the past year to close the last trading session at $81. 12% in the. XBI has an overall POWR Rating of D, equating to a Sell. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. Market Capitalization. Its fund flows were negative $259. All 142 XBI Holdings. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Mettler-Toledo International Inc. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. Total net assets. Top 10 Holdings (14. 56% vs 0. 26%. ($423. 89%. Below is the comparison between XBI and XLV. com if you have any further questions. Dividend ETFs. ARGX. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. XLV comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. The fee is slightly higher for SBIO - . comSPDR S&P Biotech ETF is a equity fund issued by SSgA. View and export this data back to 2006. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. SBIO holds 79 companies vs. XBI SPDR S&P Biotech ETF ARKG ARK Genomic Revolution ETF IBB iShares Biotechnology ETF IHI iShares U. Learn everything you need to know about SPDR® S&P Biotech ETF (XBI) and how it ranks compared to other funds. 10% of. 60 as the 52 week high point — that compares with a last trade of $70. 71. 01 to $0. Looking at the chart above, XBI's low point in its 52 week range is $62. February 15, 2023 — 10:47 am EST. Our MRNA ETF report shows the ETFs with the most MRNA exposure, the top performing MRNA ETFs, and most popular MRNA ETF strategies. The gross expense ratio is the fund’s total annual operating expenses ratio. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and. The most heavily invested institutionals were Morgan Stanley ($614. Learn everything about SPDR S&P Biotech ETF (XBI). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 49. 64 per share, with $174. Cash and Equivalents. Published. 74. Top 10 Holdings (14. S. Learn everything about SPDR S&P Biotech ETF (XBI). The fund's investments total to approximately $6. 1% which highlights the scope of the fund and diversification away from company-specific risks. Both IBB and XBI have a similar number of assets under management. 94 per share, with $121. Both ARKG and XBI are ETFs. $7. 35%. 35%). com. Seeks to track a modified. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. 97. XBI focuses on health care investments and follows the S&P Biotech Index. by Morningstar Manager Research. The Direxion Daily Cloud Computing Bull 2X Shares seek daily investment results, before fees and expenses, of 200% of the performance of the Indxx USA Cloud Computing Index. Seagen Inc Ordinary Shares. 04 per unit, that means that analysts see 73. FBT has a higher expense ratio than XBI (0. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks. Find iShares Core High Dividend ETF (HDV) top 10 holdings and sector breakdown by %. com Ltd. It can be found in the fund’s most recent prospectus. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the XBI: SPDR S&P. 20. 09% of its total assets under management. The "A+ Metric Rated ETF" field, available to ETF Database Pro members, highlights the best rated ETF in the Emerging Markets Equities category. The index and exchange-traded fund ETF are rebalanced four times a year. Jun 23, 2022 10:49AM EDT. 68%. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. 50 -0. 0. Looking at the chart above, XBI's low point in its 52 week range is $62. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. 79 in February 2021 and has fallen over (50%) to $76. Aug 4, 2021 10:47AM EDT. 66%. Health Care Fund Highlights: 137 Total Holdings $5. 15 billion. 2. Top holding Madrigal Pharmaceuticals (NASDAQ:MDGL) makes up just a 3. Its top 10 holdings account for approximately 16. The. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 1. VEEV. 7. Please call us for more information - (250). SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. 88%. The first column indicates the name of each of the funds holding XBI, with a link to that fund's top holdings. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. SPDR S&P Biotech ETF ETF holdings by MarketWatch. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. Discover historical prices for XBI stock on Yahoo Finance. LABU has a higher expense ratio than XBI (1. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. ETFs Holding XBI. ETFs are subject to market fluctuation and the risks of their underlying investments. By Holdings Channel Staff, updated Friday, November 3, 9:50 AM In total we count 672 hedge funds holding XBI as of their latest 13F filing, but among those we've sorted out just the top ten hedge funds holding XBI by largest position size, and presented them here in slideshow format. XBI currently has 133 holdings. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. Get a real-time stock price quote for XBI (SPDR S&P BIOTECH ETF). Holdings; Performance; Risk; Advertisement. View Holdings As of 09/30/2023. In trading on Monday the SPDR S&P Biotech ETF is outperforming other ETFs up about 2% on the day. Fund Analysis. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Also includes news, ETF details and other investing information. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment ResearchLearn how it impacts everything we do. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. The portfolio of Cathie Wood updated daily. 79 as the 52 week high point — that compares with a last trade of $133. 60 as the 52 week high point — that compares with a last trade of $77. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. Additionally. 2401 Millstream Rd 125 Victoria BC. Looking at the chart above, XBI's low point in its 52 week range is $62. 97. XBI has traded between $64. Follow. 20 -4. 86% so far this year and is down about -32. 48%: Number of Holdings 78: Price/Book Ratio Price/Book Ratio. Holdings. Monday's ETF Movers: XBI, QCLN. 46% YTD Daily Total Return ETF Summary. Health Care Select Sector SPDR ETF ETF holdings by MarketWatch. 18. underlying holdings of the fund. $0. VHT has a lower expense ratio than XBI (0. ETFs are subject to market fluctuation and the risks of their underlying investments. 84% for the trailing three-year period, which makes the fund a high risk choice in the space. , Biogen Inc. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. 5x and PE ratio is about 14x. 2013. 1% vs 0. Assets Under Management. IBB has 8. As of 9/30/23. 73. 88 ; Annual Dividend & Yield 0. Performance and Risk The ETF has lost about -3. 2. 58. XBI. . 40. Market Capitalization. Free ratings, analyses, holdings, benchmarks, quotes, and news. 2 %. XBI / SPDR Series Trust - SPDR Biotech ETF short borrow fee rates are shown in the following table. The vast majority of XBI holdings have less than a 1% allocation in the fund. I have thoroughly reviewed the holdings of the XBI and have come away impressed with how broad-based the composition of the ETF is. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). IBB has a higher 5-year return than XBI (0. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Unlock comprehensive insights, track. 06 as the 52 week high point — that compares with a last trade of $109. At midday the XBI is rebounding indicating there is buying interest near $101. Both IBB and XBI are ETFs. 2. 35%. XBI has traded between. There is no overlap of the top 10 holdings between SBIO and XBI. The beaten-down prices offer a solid buying opportunity for investors. $0. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). News & World Report, XBI enjoys volume of 20. In contrast, most. Its fund flows were negative $259. It's trading down (17%) versus LABU, down (68%) in one-year performance. The weighted harmonic average of closing market price divided by. Looking at the chart above, XBI's low point in its 52 week range is $62. $156. 07. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. Free ratings, analyses, holdings, benchmarks, quotes, and news. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 26 during this last 52-week period. XBI: SPDR® S&P Biotech ETF: 1. 79 as the 52 week high point — that compares with a last trade of $76. Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. 10 as of November 2, 2022. Discover historical prices for XBI stock on Yahoo Finance. Performance and Risk The ETF has lost about -29. XBI has a Diversified Portfolio. Warren Buffett is known for holding onto his S&P 500 stocks forever. Lucy Brewster | Nov 10, 2023. 12% in the last one year (as. XBI's top 10 holdings account for about 14. XBI has a beta of 1. 12% in the. Immunovant Inc. The ETF has lost about -12. 12%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. Download as Image. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. 47%. Net expense ratio. Up vote for PJP but it is pharmaceutical focused and technically not as broad as other biotech ETF's, though the top 10 holdings are comparable. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). The current portfolio value is calculated to be $6. S. Dividend Yield. XBI is one of a handful of biotech ETFs available, offering exposure to a corner of the market that can perform well during periods of consolidation and is capable of big jumps in the event of major drug approvals. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. GrowthStrategy: Traditional growth investing is an investment. Learn everything about iShares Biotechnology ETF (IBB). XBI, MDGL, SGEN, NTRA: ETF Outflow Alert. 69% allocation. Implied XBI Analyst Target Price: $135. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.